Add Reply
Add Comment As A Guest
Close Topic OptionsHyperion Clal Biotech
Hyperion Clal Biotech - Psychology, Special Needs, Health - Posted: 8th Oct, 2014 - 12:30am
Posts: 1 - Views: 371
Biotechnology News
Post Date: 8th Oct, 2014 - 12:30am / Post ID: #
NOTE: Informer [?]
Hyperion Clal Biotech
Hyperion Clal Biotech Resolve Dispute Over Diabetes Drug
Biotechnology News
JERUSALEM (Reuters) - Hyperion Therapeutics and Clal Biotechnology Industries said they agreed to resolve their dispute after Hyperion halted development of a diabetes drug it bought from Clal due to manipulation of trial data. Hyperion had bought Israel's Andromeda Biotech - which is developing DiaPep277, a treatment for Type I diabetes that is undergoing a second advanced clinical study - from Clal for $12.5 million in June. The deal included milestone payments reaching $570 million. But in September, U.S. ...
Source
Sponsored Links:
TOPIC: Hyperion Clal Biotech